An experimental weight loss drug tested in mice targets five receptor systems and may reduce side effects, according to a ...

Adults with T1D who receive GLP-1-based therapy may have a lower risk for adverse cardiovascular outcomes and no significant ...

Add Yahoo as a preferred source to see more of our stories on Google. According to the WHO, more than 800 million people around the world have diabetes, with more than half of them not receiving ...

Ozempic is now available in pill form for people with type 2 diabetes. Novo Nordisk says the oral GLP-1's new lower-dose ...

Type 2 diabetes affects millions of people worldwide and now a new international study, jointly led by Adelaide University, ...

GLP-1 drugs like Ozempic and Wegovy offer surprising benefits beyond weight loss, but also carry unexpected risks.

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re one of the millions of adults worldwide who heard about Novo Nordisk’s ...

GLP‑1 and next‑generation obesity drugs are gaining traction across the U.S. and globally, which is good news for investors.

New research published today in JAMA Network Open offers illuminating evidence suggesting there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and ...

The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable semaglutide, the active ingredient in weight loss juggernauts Wegovy and ...

A ‘big’ data study links the diabetes and weight-loss drugs to better long-term survival after breast cancer. Critics are ...

But a new study is showing that cannabis could actually have surprising effects on your waistline.  Researchers at UC ...